Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease

Journal of Bone and Mineral Research

Volumn 25, Issue 9, 2010, Pages 1931-1940

  Kulak, Carolina A M ^a,b,c   Borba, Victoria C ^a   Jorgetti, Vanda ^d   Dos Reis, Luciene M ^d   Liu, Xiaowei S ^b   Kimmel, Donald B ^e   Kulak Jr , Jaime ^a   Rabelo, Leda M ^a   Zhou, Hua ^c   Guo, X Edward ^f   Bilezikian, John P ^b   Boguszewski, Cesar L ^a   Dempster, David W ^b,c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b College of Physicians and Surgeons ^*  (United States)

^c HELEN HAYES HOSPITAL   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Columbia University ^*  (United States)

Author keywords

Bone histomorphometry; Copd; Inhaled glucocorticoid5; Micro computed tomography; Secondary osteoporosis

Indexed keywords

TETRACYCLINE;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE STRUCTURE; CANCELLOUS BONE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HUMAN; HUMAN TISSUE; MORPHOMETRICS; OSSIFICATION; POROSITY; POSTMENOPAUSE; SMOKING; TRABECULAR BONE; VERTEBRA FRACTURE;

ADMINISTRATION, INHALATION; AGED; BIOPSY; BONE AND BONES; BONE DENSITY; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956859699     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.88     Document Type: Article

References (56)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532-555.
2. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27:188-207.
3. Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5:133-138.
4. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007;101:177-185. (Pubitemid 44835231)
5. Franco CB, Paz-Filho G, Gomes PE, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int. 2009;20:1881-1887.
6. Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007;40:493-497.
7. Li L, Brennan KJ, Gaughan JP, Ciccolella DE, Kuzma AM, Criner GJ. African Americans and men with severe COPD have a high prevalence of osteoporosis. COPD. 2008;5:291-297.
8. Maggi S, Siviero P, Gonnelli S, et al. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom. 2009;12:345-352.
9. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34:209-218.
10. Nuti R, Siviero P, Maggi S, et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int. 2009;20:989-998.
11. Carter JD, Patel S, Sultan FL, et al. The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med. 2008;102:1165-1172.
12. Kjensli A, Falch JA, Ryg M, et al. High prevalence of vertebral deformities in COPD patients: relationship to disease severity. Eur Respir J. 2009;33:1018-1024.
13. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int. 1998;8:261-267.
14. Dubois EF, Roder E, Dekhuijzen PN, Zwinderman AE, Schweitzer DH. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest. 2002;121:1456-1463. (Pubitemid 34499655)
15. Gluck O, Colice G. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest. 2004;125:1859-1876.
16. Biskobing DM. COPD and osteoporosis. Chest. 2002;121:609-620.
17. Forli L, Mellbye OJ, Halse J, Bjortuft O, Vatn M, Boe J. Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm Pharmacol Ther. 2008;21:188-195.
18. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179:630-636.
19. Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007;18:1197-1202.
20. Dimai HP, Domej W, Leb G, Lau KH. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res. 2001;16:2132-2141. (Pubitemid 32995406)
21. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res. 1988;3:133-144.
22. Dos Reis LM, Batalha JR, Munoz DR, et al. Brazilian normal static bone histomorphometry: effects of age, sex, and race. J Bone Miner Metab. 2007;25:400-406.
23. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
24. Dempster DW, Parisien M, Silverberg SJ, et al. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab. 1999;84:1562-1566.
25. Kim CH, Zhang H, Mikhail G, et al. Effects of thresholding techniques on microCT-based finite element models of trabecular bone. J Biomech Eng. 2007;129:481-486.
26. Hildebrand T, Ruegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc. 1997;185:67-75. (Pubitemid 27060526)
27. Muller R, Hildebrand T, Ruegsegger P. Non-invasive bone biopsy: a new method to analyse and display the three-dimensional structure of trabecular bone. Phys Med Biol. 1994;39:145-164.
28. Ding M, Hvid I. Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone. Bone. 2000;26:291-295.
29. Odgaard A, Gundersen HJ. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone. 1993;14:173-182. (Pubitemid 23098966)
30. Cowin SC. Wolff's law of trabecular architecture at remodeling equilibrium. J Biomech Eng. 1986;108:83-88.
31. Parisien M, Cosman F, Morgan D, et al. Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res. 1997;12:948-957.
32. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
33. McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in oldermen with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:704-709.
34. Incalzi RA, Caradonna P, Ranieri P, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med. 2000;94:1079-1084.
35. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002;122:1949-1955. (Pubitemid 36051130)
36. Dempster DW. Bone microarchitecture and strength. Osteoporos Int. 2003;14:S54-S56.
37. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int. 1985;37:594-597.
38. Aaron JE, Shore PA, Shore RC, Beneton M, Kanis JA. Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology. Bone. 2000;27:277-282.
39. Bousson V, Meunier A, Bergot C, et al. Distribution of intracortical porosity in human midfemoral cortex by age and gender. J Bone Miner Res. 2001;16:1308-1317.
40. Crabtree N, Loveridge N, Parker M, et al. Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography. J Bone Miner Res. 2001;16: 1318-1328. (Pubitemid 32574661)
41. Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB. Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). Osteoporos Int. 2009;20:399-408.
42. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16:155-162.
43. Nakayama Y, Mezawa M, Araki S, et al. Nicotine suppresses bone sialoprotein gene expression. J Periodontal Res. 2009;44:657-663.
44. Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R. Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab. 2009;27:555-561.
45. Kamer AR, El-Ghorab N, Marzec N, Margarone JE 3rd, Dziak R. Nicotine induced proliferation and cytokine release in osteoblastic cells. Int J Mol Med. 2006;17:121-127.
46. Park JH, Park BH, Kim HK, Park TS, Baek HS. Hypoxia decreases Runx2/Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol. 2002;192:197-203.
47. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1179-1184.
48. Fujimoto H, Fujimoto K, Ueda A, Ohata M. Hypoxemia is a risk factor for bone mass loss. J Bone Miner Metab. 1999;17:211-216. (Pubitemid 29403932)
49. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:1286-1293.
50. Johnell O, Pauwels R, Lofdahl CG, et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J. 2002;19:1058-1063.
51. Matsumoto H, Ishihara K, Hasegawa T, Umeda B, Niimi A, Hino M. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal study. Chest. 2001;120:1468-1473.
52. Scanlon PD, Connett JE, Wise RA, et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004;170:1302-1309.
53. Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos Int. 1993;3:97-102. (Pubitemid 23088903)
54. Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int. 1983;35:410-417.
55. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med. 1985;103:350-356.
56. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128:3792-3798.